Stock News
Kenai Therapeutics Expands Research Operations: New Facility at Lilly Gateway Labs
Kenai Therapeutics Establishes Research Facilities in San Diego to Advance Neuron Replacement Therapies San Diego, CA – Kenai Therapeutics, a pioneering biotechnology company, has recently announced the establishment of its research and laboratory facilities at Lilly Gateway Labs (Gateway Labs) in San Diego. This move comes as part of a strategic partnership with Alexandria Real…
Kraft Heinz Unveils Fourth Quarter and Full Year 2024 Financial Results: An In-Depth Analysis
Kraft Heinz Reports Q4 and Full Year 2024 Financial Results: A Closer Look The Kraft Heinz Company, a leading global food and beverage manufacturer, recently released its financial results for the fourth quarter and full year 2024. In the face of a challenging year, the Company maintained a strong focus on profitability and generated impressive…
Altair Unveils Plans for FutureIndustry 2025 Global Event: A Look Ahead to the Future of Technology and Innovation
Future.Industry 2025: A Virtual Gathering of Thought Leaders and Industry Experts Altair, a global leader in computational intelligence, is set to host its annual flagship event, Future.Industry 2025. This year, the event will be held virtually on March 5-6, 2025. Despite the shift to a virtual format, the company promises an engaging and thought-provoking experience…
Orchard Therapeutics’ New CCO and Exciting Business Updates: Robin Kenselaar Takes the Commercial Reins for Their Gene Therapy for MLD
Lenmeldy™: The Game-Changer in Gene Therapy, Making Waves in the US Have you heard about Lenmeldy™, the latest breakthrough in gene therapy? This revolutionary treatment, also known as atidarsagene autotemcel, has recently started making heads turn in the US as the first patients are being treated in a commercial setting. A Leap Forward in Medical…
Lightbridge Achieves Milestone in Nuclear Technology: Co-Extrudes Uranium-Zirconium Alloy and Cladding to Produce Demonstration Sample
Lightbridge Achieves Significant Nuclear Fuel Development Milestone at Idaho National Laboratory Lightbridge Corporation, a leading advanced nuclear fuel technology company, recently announced a noteworthy accomplishment in its ongoing efforts to innovate nuclear fuel development. This milestone was marked by the successful co-extrusion of a coupon sample at Idaho National Laboratory (INL). The Co-extrusion Process The…
Boralex Announces Dividend Declaration: Detailed Information for Shareholders
Boralex Declares Eligible Quarterly Dividend: On February 12, 2025, Boralex Inc. (Boralex) announced the declaration of a quarterly dividend for its common shareholders. The dividend amount is set at $0.165 per share. Details of the Dividend: The dividend is eligible within the meaning of Section 89(14) of the Income Tax Act (Canada) and all applicable…
Aligos Therapeutics Charms Investors with $105 Million Private Placement Financing: A New Milestone in Their Biotech Journey
Exciting News from Aligos Therapeutics: $105 Million Private Placement to Fuel Phase 2 Clinical Study South San Francisco-based Aligos Therapeutics, a pioneering biotech company specializing in liver and viral diseases, recently made headlines with a significant financial development. The company announced a private placement agreement that is projected to generate approximately $105 million in gross…
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation into IIPR – Your AI Friend’s Got Your Back in Business News
Bronstein, Gewirtz & Grossman, LLC: A Class Action Lawsuit Against Innovative Industrial Properties, Inc. In the bustling city of New York, amidst the cacophony of honking taxis and chattering crowds, a significant legal development unfolded. On February 12, 2025, Bronstein, Gewirtz & Grossman, LLC, a renowned law firm, took the first step towards seeking redress…